Teprotumumab, a Human Monoclonal Antibody Insulin-like Growth Factor-1 Receptor Inhibitor for Thyroid Eye Disease

Author Affiliation: Nurse Researcher/Scientist, Premier Health - Miami Valley Hospital, Dayton, Ohio. The author reports no conflicts of interest. Correspondence: Patricia Anne O'Malley, PhD, APRN-CNS, Premier Health - Miami Valley Hospital, 1 Wyoming Street, Dayton, OH 45409 ([email protected]; [email protected]).